Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -3 of 3 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Immunotherapy for Colorectal Cancers Using CEA-Pulsed Dendritic Cells and Subsequent IL-2 Treatment

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				20 to 75				Other				27MD02 NCT00154713

Last Modified: 12/9/2008 First Published: 3/18/2008


2.		Phase I Randomized Study of Cytomegalovirus-Targeted Anti-Tumor Immunotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Biomarker/Laboratory analysis, Treatment				Active				18 and over				NCI				DUMC-PRO00003877 Pro00003877, DUMC-8108-07-1R1, NCT00639639, NCI-09-C-0038


3.		Vaccination With Tetanus and KLH to Assess Immune Responses.

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Biomarker/Laboratory analysis, Treatment				Active				18 to 55				NCRR				NCRR-M01RR00400-0626 M01RR00400, NCT00000105

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute